Traven Lea was a member of the first cohort of Masters of Applied Epidemiology (Indigenous Health) students. As a mature age student, he completed a Diploma in Public Health & Tropical Medicine before enrolling in NCEPH's MAE program. Traven now manages a national program for the National Heart Foundation, developing strategies to address the cardiovascular health of Indigenous Australians.
After graduating in 2000, Traven took on the management of the NACCHO Trial which investigated the effectiveness of antibiotics in treating Aboriginal children with otitis media. Otitis media is a largely preventable problem, but remains a scourge of Aboriginal children. Among its potential consequences are hearing problems which have social, educational and employment implications. The research team looked at exploring the efficacy of ototopical ciprofloxacin compared with traditional topical aminoglycoside antibiotics. They found ciprofloxacin was more effective & recommended that it be considered as front-line treatment. Although the immediate dividend of their research was the clinical outcome, what is also important is that their research demonstrates that randomised controlled trials, which are always logistical nightmares, can be conducted in Aboriginal communities, if the ownership belongs to these communities, and collaborating partners are Aboriginal organisations such as NACCHO. (Van Der Weyden)
In 2005, Traven and his research team were awarded the MJA/Wyeth Award. This award goes to the best research article published in the Medical Journal of Australia (MJA) each year, as judged by the Editors and Content Review Committee of the MJA. Traven was the second author on the winning article - “Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: a community-based, multicentre, double-blind randomised controlled trial”, by Sophie Couzos, Traven Lea, Reinhold Mueller, Richard Murray and Margaret Culbong, (179:185-190). The prize money of $10,000 is donated by Wyeth Australia as part of its committment to encouraging excellence in clinical research.
In commenting on the research, Dr Michael Lee (Medical Director, Wyeth Australia ) noted the article opens with the following words: “Chronic suppurative otitis media (CSOM) is a disease of poverty. It is very common among Australian Aboriginal children, with the prevalence exceeding World Health Organization's definition of ‘massive' public health problem”.
What set this winning research apart was its relevance and timeliness to an area of health with an impact on many children across the country. |